Carlisle Companies Incorporated (CSL)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 5,816,600 6,478,400 6,728,300 6,645,900 6,620,000 6,816,000 7,176,200 7,115,400 7,222,000 7,732,000 7,577,700 7,323,000 7,246,800 7,074,600 5,839,300 5,752,200 5,866,400 5,800,000 5,808,300 6,297,600
Total stockholders’ equity US$ in thousands 2,463,300 2,762,900 3,004,300 2,859,300 2,829,000 2,923,800 3,032,000 3,058,300 3,024,400 3,041,700 2,875,100 2,678,600 2,629,500 2,544,800 2,417,900 2,411,800 2,537,700 2,475,300 2,516,200 2,518,500
Financial leverage ratio 2.36 2.34 2.24 2.32 2.34 2.33 2.37 2.33 2.39 2.54 2.64 2.73 2.76 2.78 2.42 2.39 2.31 2.34 2.31 2.50

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $5,816,600K ÷ $2,463,300K
= 2.36

The financial leverage ratio of Carlisle Companies Incorporated has shown fluctuations over the reporting periods provided. The ratio stood at 2.50 as of March 31, 2020, and gradually declined to 2.31 by June 30, 2020. However, it slightly increased to 2.34 by September 30, 2020, and remained relatively stable around 2.31 to 2.42 until June 30, 2021.

Thereafter, the ratio witnessed a significant increase, reaching 2.78 by September 30, 2021. The trend continued with a minor decrease to 2.76 by December 31, 2021. Subsequently, the financial leverage ratio declined consistently to reach 2.24 by June 30, 2024, before showing a slight increase to 2.36 by December 31, 2024.

Overall, Carlisle Companies Incorporated's financial leverage ratio has shown variability over the periods analyzed, with both upward and downward movements indicating changes in the company's leverage position and financial structure.


Peer comparison

Dec 31, 2024

Company name
Symbol
Financial leverage ratio
Carlisle Companies Incorporated
CSL
2.36
West Pharmaceutical Services Inc
WST
1.36